SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 6, 2008 (April 29, 2008)
GUIDED THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware (State or Other Jurisdiction of Incorporation) |
0-22179 (Commission File Number) |
58-2029543 (IRS Employer Identification No.) |
4955
Avalon Ridge Pkwy, Suite 300 |
30071 |
Registrant's Telephone Number, Including Area Code: (770) 242-8723
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 7.01. REGULATION FD DISCLOSURE. | ||||||||
| Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS. |
| SIGNATURES |
| EXHIBIT INDEX |
| EXHIBIT 99.1 Press release, dated May 6, 2008 |
Item 7.01. Regulation FD Disclosure.
On May 6, 2008, Guided Therapeutics, Inc. announced it entered into a collaborative option to license and no shop agreement with Konica Minolta Opto, Inc. of Tokyo, as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto, which information is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
| Exhibit No. | Exhibit Description | |
| 99.1 | Press Release, dated May 6, 2008 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GUIDED THERAPEUTICS, INC. | ||||
/s/ MARK L. FAUPEL |
||||
| By: | Mark L. Faupel, Ph.D. | |||
| President & CEO | ||||
| Date: May 6, 2008. | ||||
| Exhibit No. | Exhibit Description | |
| 99.1 | Press Release, dated May 6, 2008 |